The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) will jointly host the multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations on 12 and 13 November 2026.
The event will be held in a hybrid format, with in-person attendance (by invitation only) and online participation available.
Coordinated by the Network Data Steering Group (NDSG) in collaboration with the CHMP Methodology Working Party and the ACT EU initiative, the forum offers a valuable opportunity to engage with regulators and stakeholders from across the EU network, sharing progress updates and insights on data and artificial intelligence (AI) related activities.
The event aims to:
- Showcase state-of-the-art AI and data applications across the medicines’ lifecycle
- Discuss the evolving EU regulatory landscape for data and AI
- Hear from stakeholders on data foundations, governance, quality, and interoperability across the Network
- Strengthen stakeholder collaboration to accelerate the adoption of trustworthy AI
- Provide input to the NDSG workplan 2026-2028, in alignment with the European medicines agencies network strategy 2028
Further details, including the event programme and registration information, will follow in autumn and will be shared via updates to the event page (linked below).
More information on the link below:
https://www.ema.europa.eu/en/events/hma-ema-multistakeholder-ai-data-forum-build-trustworthy-ai-strong-data-foundations
